secwatch.observer — SEC 8-K summary
======================================

Issuer:     MIRA PHARMACEUTICALS, INC. (MIRA)
CIK:        0001904286
Form:       8-K
Filed at:   2026-08-06T12:00:18+00:00
Accession:  0001493152-26-036262
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MIRA reports positive 7-day dog study for obesity drug SKNY-1; de-risks dose selection
--------------------------------------------------------------------------------

- SKNY-1 showed rapid oral absorption and dose-dependent systemic exposure in Beagle dogs over 7 days.
- Plasma concentrations were comparable between male and female animals.
- Data demonstrates dose-dependent response and systemic accumulation with repeated dosing.
- Findings de-risk dose selection and support advancement toward GLP toxicology and IND-enabling studies.
- SKNY-1 aims to preserve lean body mass while promoting weight reduction in obesity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1904286/000149315226036262/0001493152-26-036262-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1904286/000149315226036262/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-036262

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer